COMMUNIQUÉS West-GlobeNewswire

NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction
08/04/2026
LANGHORNE, Pa., April 08, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high- [...]
Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F
08/04/2026
Daix (France), New York City (New York, United States), April 8, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies [...]
Neura Supplement Claims Evaluated: The 7-Second Red Goji Berry Recipe Memory Trick for Neura Shield Cognitive Performance
08/04/2026
A 2026 informational consumer report on the Neura Supplement red goji berry recipe memory trick, cognitive shield claims, Lion's Mane and Bacopa ingredient research context, dementogen positioning, and what adults over [...]
Sanofi - Combined General Meeting of April 29, 2026 - Availability of Preparatory documents
08/04/2026
COMBINED GENERAL MEETING OF APRIL 29, 2026 AVAILABILITY OF PREPARATORY DOCUMENTS The Company’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday April 29, 2026 at 2:30 p.m. (CET) at [...]
Booking Health Releases 2026 Report on Advanced Head and Neck Cancer Treatment for International Patients
08/04/2026
Langenfeld, Germany, April 08, 2026 (GLOBE NEWSWIRE) -- Booking Health , a global medical travel provider, announced today the release of its 2026 report on advanced head and neck cancer treatment for international [...]
Ascendis Pharma to List Ordinary Shares Directly on Nasdaq
08/04/2026
- Ordinary shares expected to commence trading on Nasdaq on April 20, 2026 following exchange of all American Depositary Shares (ADSs) - ADS holders will receive one ordinary share listed on Nasdaq for each ADS held - [...]
Sanofi - Assemblée Générale Mixte du 29 avril 2026 - Mise à disposition des documents préparatoires
08/04/2026
ASSEMBLÉE GÉNÉRALE MIXTE DU 29 AVRIL 2026 MODALITÉS DE MISE À DISPOSITION OU DE CONSULTATION DES DOCUMENTS PRÉPARATOIRES Les actionnaires de la Société sont invités à participer à l’assemblée générale mixte qui se [...]
Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model
08/04/2026
A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain cancer model that [...]
New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects
08/04/2026
23andMe turns research into useful genetic insights, now offering a new GLP-1 report and interactive tool through 23andMe Total Health PALO ALTO, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a [...]
Precision Neuroscience™ Appoints Craig Mermel as Chief AI and Data Officer
08/04/2026
As brain–computer interfaces advance, neural data emerges as a key asset. NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leading brain–computer interface (BCI) company, [...]
Biora Therapeutics Advances BioJet™ Swallowable Autoinjector
08/04/2026
Company reports >25% oral bioavailability in swine and non-human primates Progressing multiple collaborations toward partnerships SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Biora Therapeutics, a biotech company [...]
Spectral AI Names David McGuire, CPA, as Chief Financial Officer
08/04/2026
DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate [...]
Life Biosciences Secures $80 Million Series D Financing
08/04/2026
Funding to support the Phase 1 clinical trial of ER-100 in optic neuropathies and further investigation of new candidates from the company’s Partial Epigenetic Reprogramming platform BOSTON, April 08, 2026 (GLOBE [...]
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
08/04/2026
PRINCETON, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, [...]
Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026
08/04/2026
THE WOODLANDS, TX, April 08, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference
08/04/2026
Virtual presentation scheduled for Thursday, April 16th at 2:15 PM ET Access the webcast here Denver, CO, April 08, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical- [...]
Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
08/04/2026
BRISBANE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, [...]
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
08/04/2026
Partnership Signals Commercial Readiness and Manufacturing Strength for Groundbreaking Ophthalmic Treatment COLUMBIA, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- The Ritedose Corporation, Inc. (Ritedose), the largest [...]
Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference
08/04/2026
WAYNE, Pa., April 08, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]

Pages